Brii Biosciences Limited (HK:2137) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Brii Biosciences Limited reassured stakeholders that VBI Vaccines Inc.’s insolvency will not materially impact its operations or financial performance. The company holds exclusive licenses for BRII-179 and PreHevbri in the Asia Pacific region and has already planned for the clinical studies and manufacturing transfers for BRII-179. Investors are reminded to exercise caution and seek professional advice when dealing with the company’s shares.
For further insights into HK:2137 stock, check out TipRanks’ Stock Analysis page.